These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 1876981

  • 1. Regression of phenytoin-induced gingival overgrowth after withdrawal of medication.
    Dahllöf G, Axiö E, Modéer T.
    Swed Dent J; 1991; 15(3):139-43. PubMed ID: 1876981
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of phenytoin-induced gingival overgrowth in non-institutionalized epileptic children subjected to different plaque control programs.
    Modéer T, Dahllöf G.
    Acta Odontol Scand; 1987 Apr; 45(2):81-5. PubMed ID: 2955633
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis of sulfated glycosaminoglycans by human gingival fibroblasts from phenytoin-induced gingival overgrowth in vitro.
    Dahllöf G, Hjerpe A.
    Scand J Dent Res; 1987 Jun; 95(3):250-5. PubMed ID: 3474765
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of 5,5-diphenylhydantoin on a gingival hyperplasia development.
    Drízhal I, Spacek J, Hrdinová V, Lichý J, Kaut V.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980 Jun; 23(5):625-89. PubMed ID: 6972082
    [No Abstract] [Full Text] [Related]

  • 12. [Gingival hyperplasia in epileptic patients treated with diphenylhydantoin. Study by light and electron microscopy].
    Tsutsumi V, Hara Ortíz F, Alvarez Fuertes G.
    Rev Invest Salud Publica; 1973 Jun; 33(3-4):1-16. PubMed ID: 4791088
    [No Abstract] [Full Text] [Related]

  • 13. Diphenylhydantoin-induced gingival overgrowth in man: a clinico-pathological study.
    Peñarrocha-Diago M, Bagán-Sebastián JV, Vera-Sempere F.
    J Periodontol; 1990 Sep; 61(9):571-4. PubMed ID: 2213467
    [Abstract] [Full Text] [Related]

  • 14. Dental root abnormalities and gingival overgrowth in epileptic patients receiving anticonvulsant therapy.
    Girgis SS, Staple PH, Miller WA, Sedransk N, Thompson T.
    J Periodontol; 1980 Aug; 51(8):474-82. PubMed ID: 6931209
    [Abstract] [Full Text] [Related]

  • 15. [Histopathology of gingival manifestations of hydantoin therapy].
    Hanzély B.
    Fogorv Sz; 1976 Aug; 69 Suppl():418-20. PubMed ID: 1071997
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of phenytoin on cytoplasmic free Ca2+ level in human gingival fibroblasts.
    Modéer T, Brunius G, Mendez C, Juntti-Berggren L, Berggren PO.
    Scand J Dent Res; 1991 Aug; 99(4):310-5. PubMed ID: 1771377
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Images in clinical medicine. Gingival hyperplasia induced by phenytoin.
    Sharma S, Dasroy SK.
    N Engl J Med; 2000 Feb 03; 342(5):325. PubMed ID: 10655531
    [No Abstract] [Full Text] [Related]

  • 20. Oral health in non-institutionalized epileptic children with special reference to phenytoin medication.
    Modéer T, Dahllöf G, Theorell K.
    Community Dent Oral Epidemiol; 1986 Jun 03; 14(3):165-8. PubMed ID: 3459615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.